Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20210913052466N1Phase 2Completed
Phase 2, randomised trial of calcium (2 arms), sponsored by Tabriz University of Medical Sciences. Primary endpoint: Short-term clinical consequences of calcium administration mode. Started Sep 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20210913052466N1.